Vaa Brianna, Kohli Manish, Price Katharine A, Swetz Keith Mark
Mayo Clinic, Rochester, Minnesota, USA.
Mayo Clinic, Rochester, Minnesota, USA Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
BMJ Case Rep. 2014 Jun 11;2014:bcr2013200137. doi: 10.1136/bcr-2013-200137.
Transitional cell carcinoma of the bladder (TCC) represents nearly 90% of genitourinary malignancies and typically presents with locally invasive symptoms. Metastasis to the central nervous system (CNS) is uncommon occurring in <5% of patients. When present, metastatic lesions are typically solid, isolated and located in the cerebrum. We report a case of a patient with a history of TCC who presented with lethargy and ataxia and was found to have a solitary cystic cerebellar lesion consistent with metastatic disease. Unfortunately, the prognosis for patients with TCC and CNS metastases is poor. Treatment options include debulking surgery, whole brain radiation, stereotactic radiosurgery and chemotherapy. Unfortunately, treatment may not appreciably extend survival and care is often supportive in previously reported cases. Though uncommon, TCC can metastasise to the CNS and should be considered in the differential diagnosis of patients, particularly those who were treated with aggressive surgery or combination chemotherapy previously.
膀胱移行细胞癌(TCC)占泌尿生殖系统恶性肿瘤的近90%,通常表现为局部浸润症状。转移至中枢神经系统(CNS)并不常见,发生率<5%。出现转移时,病变通常为实性、孤立性且位于大脑。我们报告一例有TCC病史的患者,该患者出现嗜睡和共济失调,经检查发现有一个与转移性疾病相符的孤立性小脑囊性病变。不幸的是,TCC合并CNS转移患者的预后较差。治疗选择包括减瘤手术、全脑放疗、立体定向放射外科和化疗。不幸的是,治疗可能无法显著延长生存期,在既往报道的病例中,治疗往往以支持治疗为主。虽然不常见,但TCC可转移至CNS,在患者的鉴别诊断中应予以考虑,尤其是那些曾接受积极手术或联合化疗的患者。